Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-18 Sale | 2024-12-20 5:00 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 4,693 | $11.41 | $53,547 | 99,760 (Direct) | View |
| 2024-12-18 Sale | 2024-12-20 5:00 pm | Cullinan Therapeutics Inc. | CGEM | Jones Jeffrey Alan Chief Medical Officer | 4,632 | $11.41 | $52,851 | 114,059 (Direct) | View |
| 2024-12-18 Sale | 2024-12-20 5:00 pm | Cullinan Therapeutics Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer | 3,482 | $11.41 | $39,730 | 90,651 (Direct) | View |
| 2024-12-12 Sale | 2024-12-16 5:00 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 3,489 | $12.52 | $43,682 | 104,453 (Direct) | View |
| 2024-11-05 Sale | 2024-11-07 5:30 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 8,000 | $15.64 | $125,120 | 107,942 (Direct) | View |
| 2024-09-05 Sale | 2024-09-09 5:30 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 8,000 | $18.09 | $144,720 | 115,942 (Direct) | View |
| 2024-07-05 Sale | 2024-07-09 5:30 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 8,000 | $16.33 | $130,640 | 123,942 (Direct) | View |
| 2024-05-06 Sale | 2024-05-08 7:30 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 63,606 | $28.25 | $1,796,676 | 401,162 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 9:35 pm | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $16.18 | $647,200 | 236,321 (Direct) | View |
| 2024-01-29 Sale | 2024-01-30 7:00 pm | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $14.09 | $563,600 | 276,321 (Direct) | View |
| 2024-01-22 Sale | 2024-01-24 5:00 pm | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $12.31 | $492,508 | 215,300 (Direct) | View |
| 2023-12-26 Sale | 2023-12-27 6:30 pm | Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO | 4,272 | $9.24 | $39,473 | 111,550 (Direct) | View |
| 2023-12-21 Sale | 2023-12-22 5:30 pm | Cullinan Oncology Inc. | CGEM | Jones Jeffrey Alan Chief Medical Officer | 1,860 | $8.5 | $15,810 | 56,191 (Direct) | View |
| 2023-12-21 Sale | 2023-12-22 5:30 pm | Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer | 1,400 | $8.5 | $11,900 | 44,133 (Direct) | View |
| 2023-12-21 Sale | 2023-12-22 5:30 pm | Cullinan Oncology Inc. | CGEM | Trigilio Jeffrey Chief Financial Officer | 1,920 | $8.5 | $16,320 | 83,919 (Direct) | View |
| 2023-12-21 Sale | 2023-12-22 5:30 pm | Cullinan Oncology Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 1,145 | $8.5 | $9,733 | 87,582 (Direct) | View |
| 2023-12-18 Sale | 2023-12-20 6:00 pm | Cullinan Oncology Inc. | CGEM | Jones Jeffrey Alan Chief Medical Officer | 386 | $8.22 | $3,173 | 58,051 (Direct) | View |
| 2023-12-18 Sale | 2023-12-20 6:00 pm | Cullinan Oncology Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 238 | $8.22 | $1,956 | 88,727 (Direct) | View |
| 2023-12-18 Sale | 2023-12-20 6:00 pm | Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer | 290 | $8.22 | $2,384 | 45,533 (Direct) | View |
| 2023-12-18 Sale | 2023-12-20 6:00 pm | Cullinan Oncology Inc. | CGEM | Trigilio Jeffrey Chief Financial Officer | 398 | $8.22 | $3,272 | 85,839 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-08 Option Award | 2024-08-09 5:00 pm | N/A 2034-08-08 | Cullinan Therapeutics Inc. | CGEM | Thistle Mary Director | 25,743 | $0 | 25,743 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-02 7:30 pm | N/A N/A | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 2,360 | $9 | 131,942 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 7:00 pm | N/A 2034-06-26 | Cullinan Therapeutics Inc. | CGEM | Webster Stephen W Director | 15,806 | $0 | 15,806 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 7:00 pm | N/A 2034-06-26 | Cullinan Therapeutics Inc. | CGEM | Rosenberg Anthony Director | 15,806 | $0 | 15,806 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 7:00 pm | N/A 2034-06-26 | Cullinan Therapeutics Inc. | CGEM | Martin Anne-Marie Director | 15,806 | $0 | 15,806 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 7:00 pm | N/A 2034-06-26 | Cullinan Therapeutics Inc. | CGEM | Ryan David P. Director | 15,806 | $0 | 15,806 (Direct) | View |
| 2024-06-10 Exercise | 2024-06-11 6:00 pm | N/A N/A | Cullinan Therapeutics Inc. | CGEM | Ebeling Thomas Director | 18,450 | $13 | 186,653 (Direct) | View |
| 2024-06-10 Exercise | 2024-06-11 6:00 pm | 2024-06-08 2033-06-07 | Cullinan Therapeutics Inc. | CGEM | Ebeling Thomas Director | 18,450 | $0 | 186,653 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-23 4:11 pm | N/A N/A | Cullinan Therapeutics Inc. | CGEM | Ebeling Thomas Director | 84,224 | $4.3 | 168,203 (Direct) | View |
| 2024-05-23 Exercise | 2024-05-23 4:11 pm | N/A 2030-10-28 | Cullinan Therapeutics Inc. | CGEM | Ebeling Thomas Director | 100,699 | $0 | 168,203 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-23 4:11 pm | N/A N/A | Cullinan Therapeutics Inc. | CGEM | Ebeling Thomas Director | 16,475 | $12.73 | 168,203 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-16 5:40 pm | N/A 2034-05-15 | Cullinan Therapeutics Inc. | CGEM | Meek David D. Director | 15,618 | $0 | 15,618 (Direct) | View |
| 2024-05-06 Exercise | 2024-05-08 7:30 pm | N/A N/A | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 55,606 | $4.3 | 401,162 (Direct) | View |
| 2024-05-06 Exercise | 2024-05-08 7:30 pm | N/A 2030-10-28 | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 55,606 | $0 | 401,162 (Direct) | View |
| 2024-04-29 Option Award | 2024-04-30 9:02 pm | N/A 2034-04-29 | Cullinan Therapeutics Inc. | CGEM | Fenton Mary Kay Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
Ownership | 2024-04-02 8:50 pm | N/A N/A | Cullinan Oncology Inc. | CGEM | Nguyen Nate Interim PAO and PFO | 0 | $0 | 224,000 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-23 5:00 pm | N/A 2034-02-22 | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 112,500 | $0 | 278,490 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-23 5:00 pm | N/A 2034-02-22 | Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO | 480,000 | $0 | 591,550 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-23 5:00 pm | N/A 2034-02-22 | Cullinan Oncology Inc. | CGEM | Trigilio Jeffrey Chief Financial Officer | 150,000 | $0 | 233,919 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-23 5:00 pm | N/A 2034-02-22 | Cullinan Oncology Inc. | CGEM | Jones Jeffrey Alan Chief Medical Officer | 187,500 | $0 | 243,691 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-23 5:00 pm | N/A 2034-02-22 | Cullinan Oncology Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 150,000 | $0 | 237,582 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-23 5:00 pm | N/A 2034-02-22 | Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer | 150,000 | $0 | 194,133 (Direct) | View |
| 2024-02-01 Exercise | 2024-02-02 9:35 pm | N/A N/A | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $4.3 | 236,321 (Direct) | View |
| 2024-02-01 Exercise | 2024-02-02 9:35 pm | N/A 2030-10-31 | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $0 | 236,321 (Direct) | View |
| 2024-01-29 Exercise | 2024-01-30 7:00 pm | N/A N/A | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $4.3 | 276,321 (Direct) | View |
| 2024-01-29 Exercise | 2024-01-30 7:00 pm | N/A 2030-10-28 | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $0 | 276,321 (Direct) | View |
| 2024-01-22 Exercise | 2024-01-24 5:00 pm | N/A N/A | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 35,875 | $4.3 | 215,300 (Direct) | View |
| 2024-01-22 Exercise | 2024-01-24 5:00 pm | N/A 2030-10-28 | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 35,875 | $0 | 215,300 (Direct) | View |